Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lusher

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Health Facilities Management|June 7, 2011
Constantly increasing membership valueP J Lusher
Vox Sanguinis|January 1, 1996
Protocols, dosages and clinical aspects of immune toleranceJ Lusher, G Mariani
British Journal of Haematology|February 13, 2001
Perinatal management of newborns with haemophiliaR Kulkarni, J Lusher
Transfusion Medicine Reviews|October 1, 1992
Clinical trials of the recombinant factor VIII product, KogenateM Inwood, J Lusher
Future Medicinal Chemistry|July 7, 2015
Finding the right approach to big data-driven medicinal chemistryScott J Lusher, Tina Ritschel
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
High-titer inhibitor development in hemophilia A: lack of product specificityW K Hoots, J Lusher
Addiction Biology|June 26, 2010
Dopamine D4 receptor gene and severity of dependenceJ Lusher, L Ebersole, D Ball
Clinical Immunology and Immunopathology|March 1, 1988
Increase in Leu 2+ Leu 7+ lymphocytes in HIV 1-seropositive patients with hemophilia repeatedly treated with clotting factor concentratesJ Kaplan, I Sarnaik, J Lusher
Thrombosis Research|October 15, 1994
Factor VIII inhibitor assay using plasma F VIII versus recombinant F VIII--a comparative studyC Hillman-Wiseman, C Vitale, J Lusher
Blood|July 1, 1984
Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusionsJ Kaplan, S Sarnaik, J Gitlin, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Health Facilities Management|June 7, 2011
Constantly increasing membership valueP J Lusher
Vox Sanguinis|January 1, 1996
Protocols, dosages and clinical aspects of immune toleranceJ Lusher, G Mariani
British Journal of Haematology|February 13, 2001
Perinatal management of newborns with haemophiliaR Kulkarni, J Lusher
Transfusion Medicine Reviews|October 1, 1992
Clinical trials of the recombinant factor VIII product, KogenateM Inwood, J Lusher
Future Medicinal Chemistry|July 7, 2015
Finding the right approach to big data-driven medicinal chemistryScott J Lusher, Tina Ritschel
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
High-titer inhibitor development in hemophilia A: lack of product specificityW K Hoots, J Lusher
Addiction Biology|June 26, 2010
Dopamine D4 receptor gene and severity of dependenceJ Lusher, L Ebersole, D Ball
Clinical Immunology and Immunopathology|March 1, 1988
Increase in Leu 2+ Leu 7+ lymphocytes in HIV 1-seropositive patients with hemophilia repeatedly treated with clotting factor concentratesJ Kaplan, I Sarnaik, J Lusher
Thrombosis Research|October 15, 1994
Factor VIII inhibitor assay using plasma F VIII versus recombinant F VIII--a comparative studyC Hillman-Wiseman, C Vitale, J Lusher
Blood|July 1, 1984
Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusionsJ Kaplan, S Sarnaik, J Gitlin, et al.
Pageof 5